These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 6142723

  • 1. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC, De A, Cameron EG.
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract] [Full Text] [Related]

  • 2. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ, Laszt A, Paran E, Ben Ari J, Goren Y, Modan M.
    Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S.
    Clin Ther; 1985 Aug; 7(2):199-204. PubMed ID: 3886142
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL, Strocchi E, Ambrosioni E, Magnani B.
    Int J Clin Pharmacol Res; 1983 Aug; 3(1):35-9. PubMed ID: 6384071
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical trial of a new antihypertensive preparation: guanfacine].
    Rengo F, Ricciardelli B, Spirito G, Volpe M, Morrone G, Trimarco B, Condorelli M.
    Boll Soc Ital Cardiol; 1979 Aug; 24(10):1097-102. PubMed ID: 400394
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N, Knaup G.
    Med Welt; 1983 Feb 04; 34(5):158-61. PubMed ID: 6341756
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Anti-hypertensive efficacy of guanfacine and methyldopa: intra-patient comparison].
    Malini PL, Strocchi E, Ambrosioni E, Magnani B.
    Cardiologia; 1982 Feb 04; 27(4):357-63. PubMed ID: 6765437
    [No Abstract] [Full Text] [Related]

  • 18. Double-blind trial comparing guanfacine and methyldopa in patients with essential hypertension.
    Bune AJ, Chalmers JP, Graham JR, Howe PR, West MJ, Wing LM.
    Eur J Clin Pharmacol; 1981 Feb 04; 19(5):309-15. PubMed ID: 7016550
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-invasive monitoring of ambulatory blood pressure and its variability in elderly hypertensive patients: effect of guanfacine.
    Dupont AG, Vanderniepen P, Six RO.
    Bibl Cardiol; 1987 Feb 04; (42):161-7. PubMed ID: 3307757
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.